Bunch of nonsense written by a hack for a community 'newspaper' which has been debunked numerous times on this forum in the past. It was poorly researched and unsubstantiated, and even deleted from the online site which hosted it.
Alternatively, it is a FACT that CTIX has Dr. Menon's discovery, Kevetrin, in a Phase I clinical trial at the world renown Harvard Cancer Centers. A trial that is going swimmingly well by all reports and right now in the range believed efficacious without yet experiencing dose limiting toxicities.
It is a fact that a clinical trial for Kevetrin is about to start at the world renowned University of Bologna. A top European cancer research center.
It is a fact Kevetrin has completed pre-clinical research at the world renown Beth Israel Deaconess, another Harvard Cancer Center affiliate, with stunning results. "Research by BIDMC combined Kevetrin™ with sunitinib on cell line 786, a drug-resistant renal cancer. Cellceutix was advised by the researchers that “the Kevetrin/sunitinib combination is the first we’ve used in which actual tumor shrinkage is noted.”CTIX PR Link
And it is a fact that M.D. Anderson, rated number 1 worldwide as a cancer research and treatment center, is engaged in pre-clinical research of Kevetrin.
So on the one hand, we have dubious and unsupported claims by a writer for a small online community newspaper who is not even still employed there, and which the online site has also removed, and on the other we have Dr. Menon's drug discovery undergoing pre-clinical research and clinical trials in several of the world's top cancer research institutes.
I trust the judgement of the world renowned cancer research centers which are actively researching Dr. Menon's discovery and totally dismiss the poorly researched hit-piece of a nobody formerly employed by a local community online media. Simple as that.
Market Data 
Markets 
AI
